Chronic autoimmune disorders are among the most difficult disease categories facing medicine today. This is one of the more severe cases and Crohn’s Disease is like this. It’s a lifetime disease and occurs due to complex interaction of genetic and environmental factors. Patients suffer from chronic inflammation in the gastrointestinal tract. It can be life changing in a number of ways due to this extreme inflammation. Severe abdominal pain, loss of appetite and weight, lasting fatigue and anemia can occur with this patients. In many cases, medicine is ineffective or only shows short term effects, creating a larger demand for more progressive treatment alternatives. The size of the pressure it puts on world healthcare systems and how long-lasting this disease can last really makes the illness hard to go through. This is one of the main motivation for exploration on Regenerative Medicine field. Opting for treating symptoms in addition to a Stem Cell Clinic instead of traditional medicine and surgical centre is the best opt. Such a new paradigm changes the focus from controlling exacerbations temporally to modifying disease to restore immune homeostasis.
Crohn’s Disease Mechanism
Rather than focusing on the outward symptoms experienced by patients with Crohn’s Disease, it is far more instructive to examine how this disease affects cellular function within our body. This condition is marked by transmural inflammation (inflammation of all layers of the intestinal wall). Tissues are damaged as a result of dysregulation within the immune response, with destructive mechanisms cascading. Mutations of the NOD2 receptors is one specific genetic anomaly that happens, making natural responses to the door coments which are gut flora unusual. The gut immune response is accompanied by a copious production of the macrophage derived cytokine TNF-α. There is also imbalance of the effector and the regulatory T cells, which causes dysregulation of immune system response that results in an endless cycle of mucosal injury. This integrates with and concentrates into the patient developing intestinal fistulas with an annoying deep-seated roots and serious Stricture. The constant erosion of the mucosa that absorbs all nutrients is why the individuals affected are malnourished, no matter how much they eat. That mental element of this disorder is to be proven painfully by the extreme consequences of the GI mutilation. The patients, are living daily with chronic pain and themselves, have all the psychological trauma generated by being in that state. The seriousness of the condition is one of the causes why a Stem Cell Clinic should provide you with a more complete treatment as this available for purchase therapy which goes beyond the suppression of symptoms.
Figure 1: Crohn’s Disease Mechanism
Traditional Treatments
The primary focus of current Crohn’s Disease medicine is to control inflammation via systemic immune suppression. In an effort to quickly control an acute flare-up, doctors will often prescribe corticosteroids. Once an initial flare is under control, the patient is usually shifted to an immunomodulator or one of the newer biologic therapies, which target the specific proteins of the inflammatory cascade. However, there are major shortcomings to these traditional approaches. The long-term use of corticosteroids has an array of significant adverse effects such as osteoporosis and increased risk of other serious infections. Biologics, while initial promising, are associated with the development of anti-drug antibodies which leads to loss of response, and the drug itself. In the event that pharmacology fails, the only course is surgical removal of the inflamed portion of the intestines. This approach is also not curative since the underlying disease persists. The anastomosis (the surgical join) becomes the new “sick” bowel and disease will often recur in a few short years. The inadequacy of current therapies demonstrates the need for Stem Cell Clinic approaches.
Stem Cell Therapy Rationale
A stem cell therapy has the potential to change how mucosal healing occurs within regenerative medicine. A stem cell therapy begins by onboarding the patient to a specialized Stem Cell Clinic, which then allows access to mesenchymal multicellular progenitors. These progenitor cells have powerful immunomodulatory effects, which can benefit Crohn’s Disease. Clinicians most often obtain these cells from umbilical cord blood/Wharton’s jelly & placental tissue for optimal regenerative effects. As these progenitor cells have the ability to migrate to actively inflamed tissues, the cells then migrate to the targets within the intestines. As such they repair the injured mucosa with potent immunomodulatory molecules. These include Paracrine molecules such as Prostaglandin E2 (PGE2) and Indoleamine 2,3-Dioxygenase (IDO), which actively antagonize destructive T effector cell responses. Additionally, the stem cells cause local macrophages to adopt an anti-inflammatory tissue repair (M2) macrophage phenotype and remove the pro-inflammatory (M1) macrophage phenotype. Because the stem cells reprogram the macrophages, they can then repair the tissue instead of inducing a generalized immune response and tissue remodeling. Furthermore, these stem cells cause the patient’s resident regulatory T (Treg) cells to hyperactively proliferate and re-establish long-term immune sequestration to the gut microbiome. This protocol is the first to resolve the root cause for the gut immunological dysregulation and promise sustained remission. This is further reinforced by the precise nature of the therapy and the modern regenerative center, which is designed with systemic immunosuppressant precautions built-in.

Upcoming Developments in Thailand
Stem Cell Clinic innovation and opportunity expand with rapid development in the Southeast. Regenerative therapies for Crohn’s Disease offer significant potential, particularly with treatment in Thailand. The country’s healthcare and legal systems support cutting-edge cellular research. Thailand’s specialization in immunology and regenerative medicine attracts international patients. Continued development in laboratory systems enhances the viability of therapeutic cell cultures, further attracting patients. Cell cultures are used in conjunction with strict quality control procedures during all steps of the cell isolation process, through to the administration to the patient. Innovative, complex autoimmune treatments place the country as a global leader. Optimizing global care standards through clinical trials designed for individualized cellular dosing. There are significant improvements anticipated in global care standards as the clinical refinements optimize the dosing and the trials are continuous.


